Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.62% |
| 2 | Technology | 7.54% |
| 3 | Financials | 6.93% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NWHM
3776
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $210K | ﹤0.01% |
62,366
-63,087
| -50% | -$166K |
|
3777
Cars.com
CARS
$722M
| $208K | ﹤0.01% |
36,034
-124,163
| -78% | -$686K |
|
3778
Huazhu Hotels Group
HTHT
$13.3B
| $208K | ﹤0.01% |
5,935
-184,302
| -97% | -$6.13M |
|
|
STSA
3779
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $207K | ﹤0.01% |
+7,190
| New | +$166K |
|
|
HTZ
3780
PUT
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $207K | ﹤0.01% |
146,500
-203,500
| -58% | -$646K |
|
3781
CALL
C.H. Robinson
CHRW
$20.5B
| $206K | ﹤0.01% |
2,600
-18,400
| -88% | -$1.39M |
|
|
DOG
3782
ProShares Short Dow30
DOG
$112M
| $206K | ﹤0.01% |
+4,296
| New | +$220K |
|
3783
Pacira BioSciences
PCRX
$1.04B
| $206K | ﹤0.01% |
3,930
-164,524
| -98% | -$6.88M |
|
|
SI
3784
DELISTED
Silvergate Capital Corporation
SI
| $206K | ﹤0.01% |
+14,692
| New | +$198K |
|
|
CSLT
3785
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $205K | ﹤0.01% |
246,609
+176,924
| +254% | +$131K |
|
3786
CALL
HCA Healthcare
HCA
$88.4B
| $204K | ﹤0.01% |
2,100
-50,000
| -96% | -$5.2M |
|
3787
NetEase
NTES
$83B
| $204K | ﹤0.01% |
2,370
-108,940
| -98% | -$8.2M |
|
3788
Nabors Industries
NBR
$1.17B
| $203K | ﹤0.01% |
5,482
-12,080
| -69% | -$347K |
|
3789
REX American Resources
REX
$1.39B
| $202K | ﹤0.01% |
17,442
-12,504
| -42% | -$124K |
|
3790
BlackRock Credit Allocation Income Trust
BTZ
$927M
| $201K | ﹤0.01% |
15,231
-10,158
| -40% | -$134K |
|
3791
CALL
Fastenal
FAST
$54.8B
| $201K | ﹤0.01% |
+9,400
| New | +$180K |
|
|
LEAF
3792
DELISTED
Leaf Group Ltd.
LEAF
| $201K | ﹤0.01% |
54,730
+34,329
| +168% | +$71.3K |
|
|
CWBC
3793
Community West Bancshares
CWBC
$685M
| $199K | ﹤0.01% |
+12,955
| New | +$179K |
|
3794
Unisys
UIS
$252M
| $199K | ﹤0.01% |
18,262
-5,629
| -24% | -$65.1K |
|
|
CEQP
3795
DELISTED
Crestwood Equity Partners LP
CEQP
| $199K | ﹤0.01% |
+15,210
| New | +$174K |
|
3796
MVB Financial
MVBF
$400M
| $197K | ﹤0.01% |
14,797
+3,369
| +29% | +$45.2K |
|
|
BRQS
3797
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
| $197K | ﹤0.01% |
782
-321
| -29% | -$107K |
|
3798
Pulse Biosciences
PLSE
$2.37B
| $196K | ﹤0.01% |
+18,763
| New | +$169K |
|
|
YI
3799
111 Inc
YI
$31.3M
| $196K | ﹤0.01% |
+3,089
| New | +$220K |
|
|
AMAG
3800
DELISTED
AMAG Pharmaceuticals
AMAG
| $196K | ﹤0.01% |
+25,625
| New | +$196K |
|
Similar funds
Millennium Management's Q2 2020 Portfolio in Review
As of Q2 2020, Millennium Management held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 8.6% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Millennium Management's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Millennium Management added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Millennium Management's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Millennium Management fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Millennium Management's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Millennium Management opened 1,140 new positions and closed 798 in Q2 2020.
- Millennium Management's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.